ABT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abbott Laboratories

Watchlist Manager

Watchlist

Price: 91.0424 CHF -4.17% Market Closed

Market Cap: CHf158.6B

A	Abbott Laboratories SIX:ABT	US
	Adicet Bio Inc NASDAQ:ACET	US
	Larimar Therapeutics Inc NASDAQ:LRMR	US
C	Camden Property Trust F:CAL	US
S	Sierra Bancorp NASDAQ:BSRR	US
I	InPlay Oil Corp F:8DA1	CA
	Kone Oyj F:KC40	FI
	Valley National Bancorp NASDAQ:VLY	US

Profitability Summary

Abbott Laboratories's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

56%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

55% > 56%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

16% > 19%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

20%

Net Margin is Increasing

13% > 14%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

14% > 16%

Positive ROE

12%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

ROIC is Increasing

9% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.